Deltu//Review
Stock market

Stock Market Roundup: Chips Drag Nasdaq, BofA Fined $1.2B

Nasdaq closes lower on chipmaker weakness as bank earnings start, BofA takes a $1.2 billion penalty, and deals from Galderma and AT&T headline Tuesday's news flow.

2026-10-14 00:20 UTCOct 14, 20263 min read
ItemFigure
BofA penalty (US government)$1.2 billion
Galderma purchase of ZO Skin Health (reported)about $1.5 billion
AT&T Mexico unit sale to Televisa and Fintech$2 billion
GameStop CEO Cohen share purchasenearly $23 million

Chip weakness weighed on the US stock market on Tuesday as the big-bank earnings cycle got going. Elsewhere, a large regulatory penalty hit Bank of America, and two sizable deals were reported.

Key takeaways

  • The Nasdaq ended lower as chipmakers fell, according to Investing.com.
  • BofA was fined $1.2 billion by the US government over suspicious-activity oversight.
  • Galderma is reported to be buying ZO Skin Health for about $1.5 billion; AT&T is selling its Mexico unit for $2 billion.
  • GameStop’s CEO bought shares worth nearly $23 million.

Stock market: chipmakers pull the Nasdaq lower

The Nasdaq finished the session down, with semiconductor shares leading the decline, according to Investing.com. The drop came as investors turned their attention to earnings from large banks. Investing.com also reported that S&P 500 futures were muted ahead of those results, with chip weakness cited as a drag.

For options traders, the setup is a familiar one. A concentrated sector decline in a heavily weighted group can move index-level exposure even when broader futures are calm. Earnings from major lenders add a scheduled catalyst. Readers tracking VIX volatility and index skew will want to see whether the chip selloff carries into the next session or fades as bank results land.

BofA hit with $1.2 billion penalty

Bank of America was fined $1.2 billion by the US government for failing to police suspicious activity, according to Investing.com. The penalty is among the larger enforcement actions reported against a US bank in this area. It lands as the sector enters its earnings window, when investors look closely at costs, provisions and compliance commentary.

Further detail on the terms, and on any remediation the bank must carry out, will matter for how the market reads the fine. Management commentary during earnings calls is the next place to look.

Deals: Galderma and ZO Skin Health, AT&T’s Mexico exit

Galderma has agreed to buy ZO Skin Health for around $1.5 billion, according to an exclusive report citing sources, published by Investing.com. The deal had not been confirmed in the report, which relied on unnamed people familiar with the matter. Watch for an official announcement and any regulatory filings.

AT&T is selling its Mexico unit to Televisa and Fintech for $2 billion, according to Investing.com. The sale continues AT&T’s pattern of narrowing its geographic footprint. Closing conditions and timing are the details to follow.

GameStop CEO buys nearly $23 million of stock

GameStop CEO Cohen purchased shares worth nearly $23 million, according to Investing.com. Insider purchases of this size draw attention from retail and institutional traders alike. They are a disclosure of activity, not a forecast, and they say little on their own about the company’s direction.

Other items on the tape

Enovix shares were reported to be surging in after-hours trading, according to Investing.com, which posed the question of what drove the move. Check the company’s own disclosures for the catalyst.

Investing.com also reported that Apple’s HomeView brings a personalized Siri to the smart home, putting the company in competition with Amazon and Google in that segment. Separately, the FBI arrested a Saudi engineer who worked at OpenAI over a covert recording device, according to the Department of Justice as cited by Investing.com. Neither item has a direct, quantified market effect in the reporting so far.

What to watch next

  • Bank earnings: results and commentary following the BofA penalty.
  • Chip stocks: whether Tuesday’s weakness extends or reverses.
  • Deal confirmations: formal word from Galderma and any filings tied to the AT&T sale.
  • After-hours movers: follow-through in Enovix at the next open.

Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.

Related